Firm may have blood test to determine presence of Alzheimer's

03/15/2007 | Yahoo!

France's ExonHit Therapeutics says it has identified a set of genes that may allow it to analyze blood samples to determine if a patient has Alzheimer's disease. In one study involving a group of 85 people, the firm said, the process was able to identify 78% of the people with Alzheimer's and 82% of those without it.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC